Drug Information

Drug General Information
Drug ID
D0KX6E
Former ID
DNCL003480
Drug Name
DI-Leu16-IL2
Indication B-cell lymphoma [ICD9: 202.8; ICD10:C85.1] Phase 1/2 [524320]
Company
Alopexx Oncology
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info Modulator [550428]
KEGG Pathway Hematopoietic cell lineage
References
Ref 524320ClinicalTrials.gov (NCT01874288) Phase I/II Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients With B-cell NHL. U.S. National Institutes of Health.
Ref 550428National Cancer Institute Drug Dictionary (drug id 599668).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.